Emerging Therapies: A free conference for patients and caregivers

Save the date for the 8th annual Emerging Therapies conference for blood cancer patients and caregivers! Local experts from Stanford University School of Medicine and University of California, San Francisco will present the latest research advances shared at the American Society of Hematology (ASH®) Annual Meeting. Last year’s attendees expressed an interest in learning more about the economics of cancer and we are pleased to announce that this year’s keynote speaker is Jamie A. Ledezma, an attorney from the Cancer Legal Resource Center.

Emerging Therapies is a free program, but space is limited and registration is required. Individuals interested in attending, can register online or call us at 866.450.0669.

2012 Emerging Therapies for Blood Cancer Patients
Saturday, January 21, 2012
9:00 a.m. – 12:30 p.m.
San Francisco Marriott Marquis (New Location)
55 Fourth Street San Francisco, CA 94103

Program Agenda
9:00 a.m. Arrival and Breakfast Served

9:30 a.m. Keynote Address
The Economics of Cancer: Jamie A. Ledezma, Esq.
Staff Attorney, Cancer Legal Resource Center

10:30 a.m. Concurrent Breakout Sessions
Chronic Lymphoid Leukemia: Steven Coutré, M.D.
Associate Professor of Medicine, Division of Hematology, Stanford University School of Medicine

Chronic Myeloid Leukemia: Neil Shah, M.D., Ph.D.
Assistant Professor, Division of Hematology/Oncology, University of California, San Francisco School of Medicine

Non-Hodgkin Lymphoma (High Grade/Aggressive): Weiyun Ai, M.D., Ph.D.
Clinical Professor of Medicine; Division of Hematology/Oncology, University of California, San Francisco

Non-Hodgkin Lymphoma (Low Grade/Indolent): C. Babis Andreadis, M.D., MSCE
Assistant Clinical Professor of Medicine, Adult Bone Marrow Transplantation Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

Multiple Myeloma: Thomas Martin, M.D.
Professor of Medicine and Associate Director of the Myeloma Institute, University of California, San Francisco

Myelodysplastic Syndromes: Jason Gotlib, M.D.
Assistant Professor of Medicine, Division of Hematology, Stanford University School of Medicine

The 2012 Northern California Emerging Therapies conference is made possible by the generosity of our partners and sponsors. 
 
2012 Partners: Association of Northern California Oncologists, Marin Specialty Care, Redwood Regional Oncology Center, Stanford Cancer Center, and University of California, San Francisco Helen Diller Family Comprehensive Cancer Center

2012 Sponsors: Celgene, Sanofi and Millennium

ASH® is a registered trademark of the American Society of Hematology. This conference is not sponsored, sanctioned, or part of the 53rd Annual Meeting of the American Society of Hematology.

Advertisements

About Megan Kilkenny

LLS Sr. Director, Marketing Communication Team In Training Alum Three-time Nike Women's Half Marathon finisher
This entry was posted in Blood Cancer Research, Honored Patient, Patient Services, Things to do and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s